Theracurmin®

The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients.

Abdolahi M, Tafakhori A, Togha M, Okhovat AA, Siassi F, Eshraghian MR, Esdighiyan M, Djalali M, Honarvar NM, Djalali M.

Immunogenetics. 2017 Jun; 69 (6): 371-378.

Safety Evaluation of Theracurmin® in Healthy Japanese Adults. ―A Randomized, Double-blind, Placebo-controlled Parallel-group Study―

Takahashi T, Iio S, Takara T.

Jpn Pharmacol Thervol. 2019 Jul 1; 47(7): 1097-1113.

Effects of Theracurmin® consumption on liver function, fatigue, and sleep: a randomized, double-blind, placebo-controlled, parallel-comparison study.

Kuwabara Y, Hirose A, Lee HJ, Hashimoto D, Iio SI, and Takara T.

Functional Food in Health and Disease 2021 11; (6): 246-269.

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T.

Cancer Chemother Pharmacol. 2012 Jan; 69 (1): 65-70.

Nano-Curcumin Inhibits Proliferation of Esophageal Adenocarcinoma Cells and Enhances the T Cell Mediated Immune Response.

Milano F, Mari L, van de Luijtgaarden W, Parikh K, Calpe S, Krishnadath KK.

Front Oncol. 2013 May 29; 3: 137.

Highly bioavailable curcumin (Theracurmin): its development and clinical application.

Imaizumi A.

PharmaNutrition. 2015 Oct; 3 (4): 123–130.